Sustained Release Excipient Market Size, Revenue Share, Drivers & Trends Analysis, 2022–2032
The global Sustained Release Excipient Market had a value of USD 140 billion in 2022 and is anticipated to reach USD 304.07 billion by 2032, with a robust compound annual growth rate (CAGR) of 9% during the forecasted period. The growth in market revenue is primarily propelled by the escalating demand for controlled drug release formulations, the prevalence of chronic diseases, and the...
0 Reviews 0 Shares